Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
OneSpaWorld Q1 2026 Earnings Call - Record Revenue Growth Driven by High-Value Medi-Spa Expansion and AI Integration
OneSpaWorld delivered a record-breaking first quarter of 2026, with total revenues jumping 13% to $247.6 million and Adjusted EBITDA rising 21% to $32.2 million. The results mark the company's 20th co...
- Total revenues increased 13% year-over-year to $247.6 million, marking the 20th consecutive quarter of record revenue.
- Adjusted EBITDA grew 21% to $32.2 million, outpacing revenue growth and highlighting margin expansion.
- Net income surged 40% to $21.3 million, or $0.21 per diluted share, driven by operational leverage and non-recurring expense adjustments.
- +7 more takeaways
Delek US Q1 2026 Earnings Call - Big Spring Turnaround Complete, EOP Target Raised to $220M, and Macro Tailwinds Favor High-Distillate Refiners
Delek US delivered a mixed Q1 2026, reporting a net loss of $201 million ($3.34 per share) driven by its Big Spring turnaround and timing in supply and marketing, though adjusted EBITDA held at $212 m...
- Big Spring Turnaround Complete: The Big Spring refinery turnaround was executed safely, on budget, and on time. The refinery is now running at full capacity with improved reliability, crude slate optimization, and higher octane/blending capabilities. This marks the highest spending quarter for turnarounds, with no further major projects planned for the rest of the year.
- EOP Target Raised: The Enterprise Optimization Plan (EOP) target has been raised to at least $220 million on an annual run-rate basis. The program contributed approximately $60 million to Q1 P&L. Management views EOP as a cultural shift rather than just a cost-saving initiative, driving value across the entire value chain.
- Q1 Financial Results: Delek reported a net loss of $201 million ($3.34 per share) and adjusted net income of $5 million ($0.08 per share). Adjusted EBITDA was $212 million. Excluding the impact of Small Refinery Exemptions (SREs), adjusted EBITDA was $129 million and adjusted EPS was a loss of $0.98 per share. The decline in EBITDA was primarily due to the Big Spring turnaround and timing in supply and marketing.
- +7 more takeaways
Santander Brasil Q1 2026 Earnings Call - CEO Mario Leão's Final Call Signals Shift to Higher-Quality Growth and AI-Driven Efficiency
Santander Brasil’s Q1 2026 results reflect a bank in transition, prioritizing portfolio quality over headline growth. CEO Mario Leão, in his final earnings call, emphasized a deliberate derisking of l...
- CEO Mario Leão’s final earnings call marks a strategic pivot toward quality over quantity, with organic earnings before tax growing 5.4% despite a quarter-on-quarter decline in net income.
- The bank is actively derisking its low-income and mass retail portfolios, which are shrinking by 4% in Q1, to free up capital for higher-yielding, collateralized segments like electric vehicles and home equity.
- Santander Rewards, a new customer loyalty program, launches to deepen engagement with high-income and SME clients, aiming to shift the franchise mix toward more profitable, sticky relationships.
- +7 more takeaways
Renasant Corporation Q1 2026 Earnings Call - Merger Integration Yields Record Profitability Amid Strategic Hiring and Stable Capital
Renasant Corporation delivered a standout first quarter of 2026, with adjusted EPS surging 41% year-over-year to $0.93, driven by the successful integration of its merger with The First. The efficienc...
- Adjusted EPS rose 41% year-over-year to $0.93, surpassing management's pre-set 2026 targets and marking a significant inflection point post-merger.
- Efficiency ratio improved sharply to 55.7% from 65.5% a year ago, reflecting the completion of major merger conversion costs and operational streamlining.
- Adjusted return on tangible equity jumped to 16.3%, up from 10.3% in Q1 2025, demonstrating enhanced profitability and capital efficiency.
- +7 more takeaways
BrightSpire Capital Q1 2026 Earnings Call - Loan Book Surges to $2.7B as Office Exposure Shrinks
BrightSpire Capital reported a solid first quarter, closing 37 new loans totaling $1.1 billion and pushing its total loan book to $2.7 billion. The company is aggressively shedding its office exposure...
- Loan book growth accelerates to $2.7 billion as the company closes 37 new loans totaling $1.1 billion in Q1 2026.
- Office exposure drops to just over 20% of the portfolio following the payoff of three office loans and the resolution of other riskier assets.
- Management targets a $3.5 billion loan book by year-end, with expectations to cross the $3 billion mark by mid-year.
- +7 more takeaways
Lennox International Q1 2026 Earnings Call - BCS Momentum Offsets Residential Headwinds Amid Tariff Pressures
Lennox International reported a mixed Q1 2026, with revenue rising 6% to $1.1 billion but segment margins contracting 130 basis points due to factory under-absorption in its struggling Home Comfort So...
- Revenue grew 6% year-over-year to $1.1 billion, marking a return to growth after two consecutive quarters of declines.
- Segment margin contracted by 130 basis points to 14.4%, primarily due to factory under-absorption in the HCS segment.
- Building Climate Solutions (BCS) delivered record quarterly performance, with organic sales up 26% and profit margins expanding 300 basis points.
- +7 more takeaways
AbbVie Q1 2026 Earnings Call - Raising Full-Year Guidance on SKYRIZI and RINVOQ Momentum
AbbVie delivered a strong start to 2026, reporting Q1 adjusted EPS of $2.65 and total net revenues of $15 billion, both beating expectations. The company raised its full-year adjusted EPS guidance to ...
- AbbVie reported Q1 2026 adjusted EPS of $2.65, beating guidance by $0.07, and total net revenues of $15 billion, up 12.4% year-over-year.
- The company raised full-year adjusted EPS guidance to $14.08-$14.28 and full-year revenue to approximately $67.3 billion, reflecting strong commercial execution.
- SKYRIZI sales reached $4.5 billion, up 29.2% on an operational basis, driven by market share gains in psoriatic disease and IBD.
- +7 more takeaways
InvenTrust Properties Q1 2026 Earnings Call - FFO Guidance Raised on Sun Belt Acquisition Momentum and Lease Commencements
InvenTrust Properties delivered a solid first quarter in 2026, reporting steady same-property NOI growth of 2.6% and raising full-year FFO per share guidance to $2.00-$2.06. Management cited strong em...
- Same-property NOI grew 2.6% year-over-year, driven by 170 bps from embedded rent escalations, 90 bps from positive leasing spreads, and 70 bps from redevelopment activity.
- Management raised full-year Nareit FFO guidance to $2.00-$2.06 per share, a 7.4% increase at the midpoint, citing mark-to-market lease adjustments from recent acquisitions.
- The company completed $123 million in acquisitions during the quarter and has an additional $167 million under contract or awarded, with most expected to close in Q2 or Q3.
- +7 more takeaways
STAG Industrial Q1 2026 Earnings Call - Data Center Tenants Fuel Record Leasing Velocity and Subdued Supply Sets Stage for Vacancy Peak
STAG Industrial reported a strong start to 2026, with record Q1 leasing velocity of 6 million square feet across 37 new leases and a 20.9% cash leasing spread. The industrial sector is benefiting from...
- STAG Industrial signed 37 new leases in Q1 2026 totaling 6 million square feet, setting a quarterly record for operating portfolio leasing volume.
- Cash leasing spreads reached a quarterly record of 20.9%, with straight-line spreads hitting 39.6%, indicating strong pricing power and tenant demand.
- Data center construction is driving a new wave of industrial leasing demand. Since 2025, STAG has signed eight leases for 1.6 million square feet to data center-related tenants, including 3PLs and equipment manufacturers, typically on long-term, high-spread contracts.
- +7 more takeaways
CTS Corporation Q1 2026 Earnings Call - Diversified Markets Drive Margin Expansion Amid Geopolitical Headwinds
CTS Corporation delivered a solid first quarter of 2026, with diversified end-market sales surging 18% year-over-year and gross margin expanding by 250 basis points to 39.5%. The company’s strategic p...
- Diversified end-market sales surged 18% year-over-year, outpacing overall revenue growth of 11% and highlighting the success of CTS’s strategic diversification.
- Gross margin expanded by 250 basis points to 39.5%, driven by operational improvements and a favorable shift toward higher-margin medical and industrial sales.
- Medical sales jumped 28% year-over-year to $25 million, fueled by robust demand in therapeutic applications, diagnostic imaging, and non-invasive aesthetics.
- +7 more takeaways